12:00 AM
 | 
Mar 16, 2015
 |  BC Week In Review  |  Clinical News  |  Regulatory

Beteflam Patch regulatory update

Health Canada accepted for review an NDS for Beteflam Patch from Cipher Pharmaceuticals Inc. (TSX:CPH; NASDAQ:CPHR, Mississauga, Ontario) to treat inflammatory skin...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >